The diagnosis of subarachnoid haemorrhage (SAH) must not be missed. Following the initial event, due to an aneurysmal bleed in 80% of patients,' immediate mortality is about 25%.2 About 10% of those with aneurysms re-bleed within hours, and about 30% within a few weeks,? with consequent mortality and morbidity. Patients with an acute re-bleed need active life support to survive) and all survivors may potentially be treated by aneurysmal clipping to prevent a further event.
The mainstay of diagnosis is the demonstration of subarachnoid blood on a computed tomography (CT) scan. This will be positive in up to 95% of those scanned within I day of the event, reducing to 90% after I day, 80% after 5 days and 50% after I week.' Following the demonstration of blood, the existence and site of the aneurysm is investigated by cerebral angiography, a procedure with its own morbidity and mortality.v' Angiography may be negative in up to 30% of patients with SAH. 6 In addition to patients who have had a haemorrhage, there will be those who present with sudden onset of severe headache-one of the key features of haemorrhage-who have not had such an event, and will thus not have demonstrable blood on a scan. This group may form up to one-third of all patients investigated for suspected haemorrhage.' Those CT negative patients who, in fact, have aneurysms may also be identified with cerebral angiography. Because of the associated risks, there is reluctance to proceed with angiography unless there is This article was prepared under the auspices of the Analytical Investigations Standing Committee of the Scientific Committee of the Association of Clinical Biochemists.
Correspondence: Dr R Beetham. supportive evidence from the less invasive procedure of lumbar puncture and investigation of cerebrospinal fluid (CSF). We will now examine the evidence for the practice of spectrophotometric examination of CSF in providing such confirmation.
VISUAL EXAMINATION OF CSF
Classically, the diagnosis of subarachnoid haemorrhage has been supported by laboratory examination of CSF to detect blood and blood products from the haemorrhage. Fluid from patients who have bled contains red blood cells unless these have been completely metabolized, usually more than 7-10 days after the bleed." Following haemorrhage, red cells lyse and release oxyhaemoglobin, which is metabolized to bilirubin. The CSF supernatant after centrifugation is visibly pink or pink-orange due to oxyhaemoglobin, yellow due to bilirubin, and an intermediate colour if both are present together. The yellow colour due to bilirubin is the entity strictly defined as visible xanthochromia, as the term implies.
Oxyhaemoglobin may be observed within 4-10 h after a bleed.P' There is more uncertainty about the time course of bilirubin appearance, variously reported as follows: exceptionally observed at 6 h after a major bleed, more usually at 3-4 days;" first seen at 9-lOh;7 or being the predominant pigment after 24h. 9 We have evidence of a bilirubin-free CSF 42 h following a proven SAH (unpublished data).
CSF may also become blood-stained during lumbar puncture (a traumatic tap). In vivo haemorrhage has traditionally been distinguished from a traumatic tap by the finding that the former results in equal staining and equal cell counts in successive collection bottles, whereas with the latter the cell count declines. While both may result in oxyhaemoglobin in the supernatant fluid, only in vivo haemorrhage Wavelength (nm)
SPECTROPHOTOMETRIC EXAMINATION OF CSF
The advent of spectrophotometry allowed the visible absorption spectrum of CSF supernatant following subarachnoid haemorrhage to be investigated.s-P-" Normal fluids are crystal clear and colourless with an essentially flat absorption spectrum ( Fig. la) . Fluids from patients after haemorrhage demonstrate oxyhaemoglobin (ab-The recommendations were!" that in suspected subarachnoid haemorrhage with a negative CT scan, unless contraindicated, a lumbar puncture should be performed at least 12 h after the presumed event. Sequential collections are made and cell counts documented. A sample is centrifuged within 6 h whether blood-stained or not and the supernatant examined visually. If 'xanthochromic', no further examination of the CSF is required, but if colourless it should be examined spectroscopically. Xanthochromia was defined as in the original definition'> as an absorbance at 415 nm of greater than 0·023 'and! or' a peak in the absorbance curve in the 450-460 nm region. 'Xanthochromia due to oxyhaemoglobiri' may be present in the absence of THE 1989 RECOMMENDATIONS--A CRITIQUE sorption peak at 4IJ-4l5nm), oxyhaemoglobin and bilirubin (additional broad peak or shoulder at 450-460 nm) or bilirubin alone (Figs Ib-d). In addition, methaemoglobin with an absorption peak at 405 nm, shifted towards 413 nm when oxyhaemoglobin is also present, may be identified ( Fig. Ie) . Discrepancy between visual description and spectrophotometric findings has been noted, with spectrophotometry being more sensitive than the eye, !1l-12 particularly with respect to oxyand methaemoglobin.
Small differences in wavelength are important to interpretation and require wavelength accuracy to be assured by regular filter checks. Where methaemoglobin is thought to be present, the apparent difference in wavelength maximum from oxyhaemoglobin can be confirmed by use of an haemolysate of fresh EDTA blood as control solution.
The use of spectrophotometry appears to be limited in the UK I 3 and visual examination is the main means of supporting the diagnosis ofSAH in patients who are CT negative. Spectrophotometry was strongly advocated by a Lancet editorial!" based on an original paper by Vermeulen and colleagues.'! It is important to understand that these workers had based the practice of spectrophotometry on the lower sensitivity of visual examination compared to spectrophotometric examination mentioned above and the unreliability ofblood counts in successivetubes in distinguishing between in vivo and traumatic bleeding." Our experience of using the recommendations in the editorial as set out below has found them to be less than sound and we now provide a critique. results in bilirubin formation through haem oxygenases in macrophages and other cells of the leptomeninges." Occasionally, methaemoglobin may be found after in vivo haemorrhage. Bilirubin may also be present in the CSF with CSF protein concentrations greater than 1·5 giL or a serum bilirubin concentration of greater than 100 Ilmol/L. 7 A traumatic tap may introduce blood into the CSF, with subsequent in vivo pigment formation. Examination of fluid taken at a subsequent puncture will thus yield false positive information. haemorrhage if a traumatic tap results in heavy contamination with blood.
Our main reservations about these recommendations concern the definition of xanthochromia, the influence of traumatic blood-staining on the CSF absorption spectrum and its subsequent interpretation, and the issue of not examining the fluid further if visually xanthochromic. To a significant extent these are inter-related.
Definition of xanthrochromia
The definition of xanthrochromia is unclear and ambiguous. The figure of 0·023 is derived from early work which indicated that this was the upper limit of absorption at 415 nm [mean (2 SO)] of normal CSF.12 As it is the presence of oxyhaemoglobin that the authors are attempting to define, we suggest that it is preferable to produce a spectrophotometric scan at the outset. An increased protein concentration will, for example, cause the absorption at 415 nm to be greater than 0·023 without oxyhaemoglobin being present. I? Ambiguity was introduced:
(a) By the words 'and/or' (b) By the statements 'Xanthochromia is caused by the presence of the haemoglobin breakdown products oxyhaemoglobin and bilirubin .. .' and' ... Xanthochromia due to oxyhaemoglobin may be detected .. .'
This definition has been interpreted by many to indicate that the necessary and sufficient conditions to define xanthochromia spectroscopically are either a peak of oxyhaemoglobin, or a peak of oxyhaemoglobin and a peak at 450 nm due to bilirubin, or a peak at 450 nm due to bilirubin alone. If this is the correct interpretation, as seems to be confirmed in a later article,' then it allows for oxyhaemoglobin alone to support the diagnosis of SAH when in practice oxyhaemoglobin may have been generated either in vivo, or in vitro with a traumatic tap.
Correction for the degree of in vitro oxyhaemoglobin formation according to the number of erythrocytes present has been deemed possible;" provided the CSF is centrifuged and the supernatant removed rapidly. Data derived from experiments in which pooled CSF is seeded with blood to mimic a traumatic tap'? indeed lead to the conclusion that, provided the fluid is centrifuged within I h of collection, the presence of up to 23250 x 10 6 erythrocytes/L will give rise to insignificant oxyhaemoglobin peaks «0·01 CSF spectrophotometry 3 absorbance units) confirming several earlier observations.s-" However, initial observations on CSF taken to investigate possible SAH indicated that oxyhaemoglobin alone may be found in the presence of relatively few cells and negative angiography, i.e. a possible false positive finding.'? A study was therefore undertaken to demonstrate whether oxyhaemoglobin occurred in patients where bleeding into the CSF was not a diagnostic consideration. Of 27 patients undergoing spinal anaesthesia, five demonstrated peak absorbances in the CSF due to oxyhaemoglobin of 0·035 or greater in the presence of erythrocyte counts ranging from only 64 x 10 6 to 705 X 10 6 per litre'? in samples which had been processed as soon as possible after puncture. We conclude that the presence of oxyhaemoglobin on its own is not a sufficient condition to confirm SAH. The key finding is the presence of those haem-derived pigments which can only be formed in vivo, namely bilirubin and methaemoglobin. The latter is unequivocally indicated by an absorbance peak below 410 nm ( Fig. Ie) .
Visual or spectrophotometric examination
The further recommendation that, if the supernatant is visibly xanthochromic there is no need to examine the CSF spectroscopically, is questionable. Even where the CSF is unequivocally yellow, we recommend spectrophotometry as a simple objective measure which provides a record of the examination. If the CSF is pink or pink-orange, as may arise from oxyhaemoglobin alone following a traumatic tap, then spectroscopic evidence for bilirubin must be sought. However, whether bilirubin is present or not may be difficult to determine from the spectral plot, as it may appear as a shoulder on, or discontinuity of, the normal oxyhaemoglobin peak (Fig. If) . Derivative spectroscopy, which has been advocated-" is not a technique necessarily available in a district hospital where rapid decisions about SAH may have to be reached. Apparently colourless fluids must always be examined spectroscopically, as the most sensitive and objective measure of the presence or absence of bilirubin and methaemoglobin.
INTERPRETATION OF A NORMAL SPECTROPHOTOMETRIC SCAN
Following spectrophotometry, what is the meaning of a normal spectrophotometric scan?
Vermeulen and colleagues concluded that xanthochromia could be demonstrated in all patients with true SAH in lumbar punctures taken between 12hand 2 weeks after the haemorrhage, implying that a spectrophotometrically normal CSF excludes SAH.lS It must be emphasized that this conclusion was based on a study of 111 patients, all with demonstrable blood on CT scan. It cannot be extrapolated to patients with no blood demonstrable by CT scan, who may be negative for a number of reasons including small bleeds.' A small group were studied, 12 in all, who had headaches, no blood on CT scan and no spectrophotometric abnormalities of the CSF.lS Three had angiography, which was normal, and all 12 were followed up for mean of 4 years with no subsequent evidence for SAH. There is, to our knowledge, no published study of patients with suspected SAH and normal CT in which CSF spectrophotometry and angiography was performed on all patients. We thus do not know the specificity of a normal spectrophotometric scan in excluding SAH.
CONCLUSION
Spectrophotometric examination of CSF may be an important investigation in patients suspected ofSAH who are CT negative, but requires further validation in this population. The presence of methaemoglobin or bilirubin or both in the CSF is strongly indicative of SAH. However, in the present state of knowledge, a normal CSF scan cannot with any degree of certainty exclude SAH, yet this is the area of greatest potential benefit. The finding of oxyhaemoglobin alone is not confirmatory of SAH. In either case, the clinician will have to make a decision about cerebral angiography on clinical grounds. A technique introduced as an advance over existing techniques has brought with it as many uncertainties as the method it was designed to replace.
